NCT07728981

Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD Patients

RecruitingEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2026-07-25Est. Completion: 2026-08-15

Enrollment target: 49 participants

Contact

Neovascular Age-related Macular Degeneration

Neovascular age-related macular degeneration (nAMD), also known as "wet" AMD, is the abnormal growth of new blood vessel…

Mesa, United StatesEst. completion Mar 2033

Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD

This is a multi-center, randomized, double-masked, active-comparator-controlled, Phase 3 study in a broad participant po…

Mesa, United StatesEst. completion Nov 15, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.